KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,355,415 | -47.8% | 43,500 | -33.1% | 0.96% | -31.6% |
| Q2 2023 | $14,095,250 | +83.6% | 65,000 | +53.8% | 1.41% | +24.4% |
| Q1 2023 | $7,678,831 | -20.4% | 42,275 | -13.9% | 1.13% | -18.2% |
| Q4 2022 | $9,644,417 | -52.9% | 49,081 | -46.1% | 1.39% | -20.1% |
| Q3 2022 | $20,469,000 | +205.3% | 91,000 | +71.7% | 1.74% | +130.2% |
| Q2 2022 | $6,705,000 | -26.6% | 53,000 | -26.4% | 0.75% | -2.0% |
| Q1 2022 | $9,129,000 | -7.1% | 72,000 | -4.0% | 0.77% | +11.6% |
| Q4 2021 | $9,825,000 | +642.6% | 75,000 | +581.8% | 0.69% | +499.1% |
| Q1 2021 | $1,323,000 | -79.7% | 11,000 | -82.8% | 0.12% | -77.4% |
| Q4 2020 | $6,502,000 | +14.4% | 64,000 | -12.9% | 0.51% | +9.5% |
| Q3 2020 | $5,683,000 | -32.0% | 73,500 | -2.0% | 0.46% | -56.9% |
| Q2 2020 | $8,359,000 | +29.0% | 75,000 | -16.7% | 1.08% | -13.0% |
| Q1 2020 | $6,480,000 | +17.8% | 90,000 | +23.3% | 1.24% | +16.9% |
| Q4 2019 | $5,500,000 | – | 73,000 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |